GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.

Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.

  • BURN@lemmy.worldEnglish
    21·
    8 months ago

    We all know it won’t stop there. Once they have it they’re going to make as much money off of it as possible.

    I’m pretty sure insurance companies already have some kind of access to this stuff, despite saying they don’t.